Brookstone Capital Management’s Anavex Life Sciences AVXL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-15,185	Closed	-$141K	–	923
2023 Q4	$141K	Hold	15,185	–	–	﹤0.01%	842
2023 Q3	$84.9K	Buy	15,185 +340	+2%	+$2.71K	﹤0.01%	809
2023 Q2	$121K	Hold	14,845	–	–	﹤0.01%	801
2023 Q1	$121K	Hold	14,845	–	–	﹤0.01%	804
2022 Q4	$148K	Buy	14,845 +145	+1%	+$1.55K	﹤0.01%	791
2022 Q3	$155K	Sell	14,700 -221	-1%	-$2.33K	﹤0.01%	753
2022 Q2	$191K	Buy	14,921 +92	+0.6%	+$871	﹤0.01%	734
2022 Q1	$168K	Buy	14,829 +893	+6%	+$11K	﹤0.01%	746
2021 Q4	$216K	Hold	13,936	–	–	﹤0.01%	696
2021 Q3	$246K	Hold	13,936	–	–	﹤0.01%	651
2021 Q2	$354K	Buy	+13,936	New	+$206K	0.01%	550